Ocular motor and sensory function in Parkinson's disease

Area of Science:

• Ophthalmology
• Neurology
• Movement Disorders

Background:

• Parkinson's disease (PD) is a neurodegenerative disorder affecting motor function.
• Ocular motor dysfunction is a common but often overlooked symptom in PD.
• The impact of dopaminergic medication and deep brain stimulation on visual function in PD requires further investigation.

Purpose of the Study:

• To assess the effects of dopaminergic medication and deep brain stimulation on ocular function in Parkinson's disease (PD).
• To quantify the vision-related quality of life in individuals with PD.

Main Methods:

• Prospective, comparative case series involving 27 PD patients and 16 controls.
• Measurements included visual acuity, ocular motor function, convergence, and the 25-item National Eye Institute Visual Function Questionnaire (VFQ-25).
• Ocular assessments were performed during both 'on' and 'off' states of dopaminergic medication.

Main Results:

• PD patients showed significantly poorer convergence amplitudes compared to controls, irrespective of medication status.
• Vision-related quality of life, particularly for near activities, was significantly reduced in PD patients.
• Dopaminergic medication improved convergence amplitudes and near point of convergence in PD patients, but did not affect visual acuity or ocular ductions.

Conclusions:

• Convergence insufficiency is a significant issue in Parkinson's disease, improving with dopaminergic treatment.
• Ocular motor function fluctuations in PD complicate ophthalmic management.
• Reduced vision-related quality of life in PD is not solely explained by visual acuity deficits.